Business
Announcement of Results
Announcement of Results.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 2811B Omega Diagnostics Group PLC 06 June 2019 \n\n \nOmega Diagnostics Group PLC\n(\"Omega\" or \"the Company\" or the \"Group\")\n \nAnnouncement of Results\n \nOmega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it will release its results for the year ended 31 March 2019 on Monday 19 August 2019.\n \n \nContacts:\n \n\n\n\n Omega Diagnostics Group PLC \n\n\nTel: 01259 763 030\n\n\n\n\nBill Rhodes, Interim Non-Executive Chairman\nColin King, Chief Executive \n\n\nwww.omegadiagnostics.com\n\n\n\n\nKieron Harbinson, Group Finance Director\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nfinnCap Ltd \n\n\nTel: 020 7220 0500\n\n\n\n\nGeoff Nash/James Thompson/ Hannah Boros (Corporate Finance)\n\n\n\n\n\n\n\nCamille Gochez (ECM)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nPaul McManus\n\n\nMob: 07980 541 893\n\n\n\n\nLianne Cawthorne\n\n\nMob: 07584 391 303\n\n\n\n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END NORSSEFIIFUSEDM\n ","...